Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 953-178-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Oral (OECD 422, rat): NOAEL fertility 300 mg/kg/day for females and 1000 mg/kg/day for males (read-across)
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- systemic
- Effect level:
- 300 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- Remarks on result:
- other: Source: CAS 59231-34-4
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- systemic
- Effect level:
- >= 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: No adverse and treatment-related effects were observed up to and inlcuding the highest tested dose level.
- Remarks on result:
- other: Source: CAS 59231-34-4
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- reproduction
- Effect level:
- 300 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- reproductive performance
- Remarks on result:
- other: Source: CAS 59231-34-4
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- reproduction
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- reproductive function (sperm measures)
- Remarks on result:
- other: Source: CAS 59231-34-4
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- developmental
- Generation:
- F1
- Effect level:
- 300 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- body weight and weight gain
- Remarks on result:
- other: Source: CAS 59231-34-4
- Key result
- Reproductive effects observed:
- yes
- Lowest effective dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Treatment related:
- yes
- Relation to other toxic effects:
- reproductive effects as a secondary non-specific consequence of other toxic effects
- Dose response relationship:
- no
- Relevant for humans:
- no
- Conclusions:
- The available data on a suitable source substance CAS 59231-34-4 did not show any toxic effect on systemic toxicity or reproduction in males, therefore the NOAEL for reproduction and for systemic toxicity was ≥ 1000 mg/kg bw/day. In females, an increase in post-implantation loss, a decrease in the birth index and a decrease in the live birth index were determined at 1000 mg/kg bw/day. However, these effects were regarded as secondary non-specific consequence of adverse effects on food consumption and body weight (gain) in maternal animals at 1000 mg/kg bw/day. The NOAEL for systemic and reproduction toxicity was therefore set at 300 mg/kg bw/day for females. As explained in the analogue justification, this result is considered to be valid also for the target substance.
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises adequate and reliable (Klimisch score 1) study from a reference substance with similar structure and intrinsic properties. Read-across is justified based on common precursors and breakdown products of hydrolysis and consistent trends in environmental fate, eco-toxicological and toxicological profile (refer to the endpoint discussion for further details). The selected study is thus sufficient to fulfil the standard information requirements set out in Annex VIII-IX, 8.7, in accordance with Annex XI, 1.5, of Regulation (EC) No. 1907/2006.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Read Across Justification
There are no data on the reproduction toxicity of the target substance Monoesters of C16 and C18 (branched and linear) fatty acids with decan-1-ol. The assessment was therefore based on a study conducted with an analogue substance as part of a read-across approach, which is in accordance with Regulation (EC) No. 1907/2006, Annex XI, 1.5. For each specific endpoint the source substance(s) structurally closest to the target substance is/are chosen for read-across, with due regard to the requirements of adequacy and reliability of the available data. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the grouping of chemicals and read-across is provided in the technical dossier (see IUCLID Section 13).
Toxicity to reproduction (fertility)
CAS 59231-34-4
A combined repeated dose toxicity and reproduction/developmental toxicity screening study was performed according to OECD guideline 422 under GLP conditions (LPT, 2013). 10 rats/sex/dose were administered 100, 300 and 1000 mg/kg bw/day 8-methylnonyl (9E)-octadec-9-enoate (CAS 59231-34-4) in corn oil once daily, via oral gavage. The control group was exposed to the vehicle. Males were exposed from two weeks before mating on test day one until 35 days after mating. Females were exposed for up to 56 days (starting 2 weeks prior to mating up to at least day 3 of lactation).
No treatment-related parental effects were seen on mortality, clinical signs. Reduction in body weight (-9.4%) and food intake (-21.7%) was seen in high dose females during gestation/lactation.
No effects on water consumption, ophthalmology, haematological parameters, clinical chemistry parameters, macroscopic and microscopic pathology were observed. The NOAEL for parental systemic toxicity was 300 mg/kg/day for females and 1000 mg/kg bw/day for males.
No effects on the reproductive function of males (qualitative sperm staging) were observed. A statistically significant increase in post implantation loss, non-statistically significant decrease in birth index, elevated number of stillbirths, leading to a statistically significant reduction in the live birth index was observed in dams of the highest dose group. These effects were regarded as secondary non-specific consequence of adverse effects on food consumption and body weight (gain) in maternal animals at 1000 mg/kg bw/day.
The NOAEL for parental fertility was 300 mg/kg bw /day for females and ≥ 1000 mg/kg bw/day for males.
Overall conclusion for effects on fertility
Analogue read-across from the source substance 8-methylnonyl (9E)-octadec-9-enoate (CAS 59231-34-4) was applied for toxicity to reproduction (fertility). Based on the available data and following the analogue approach, no hazard for reproduction toxicity was identified for the target substance Monoesters of C16 and C18 (branched and linear) fatty acids with decan-1-ol.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises adequate and reliable (Klimisch score 1) study from a reference substance with similar structure and intrinsic properties. Read-across is justified based on common precursors and breakdown products of hydrolysis and consistent trends in environmental fate, eco-toxicological and toxicological profile (refer to the endpoint discussion for further details). The selected study is thus sufficient to fulfil the standard information requirements set out in Annex VIII-IX, 8.7, in accordance with Annex XI, 1.5, of Regulation (EC) No. 1907/2006.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Developmental toxicity/teratogenicity
CAS 59231-34-4
In a combined repeated dose toxicity and reproduction/developmental toxicity screening study performed with 8-methylnonyl (9E)-octadec-9-enoate (CAS 59231-34-4) according to OECD guideline 422, the NOAEL for developmental toxicity was found to be 300 mg/kg bw per day. This NOAEL was based on effects on the viability and litter weight of foetuses seen in the highest dose group at 1000 mg/kg bw per day. The effects were regarded as secondary non-specific consequences of adverse effects on food consumption and body weight (gain) in maternal animals at 1000 mg/kg bw/day.
Justification for classification or non-classification
According to Article 13 of Regulation (EC) No. 1907/2006 "General Requirements for Generation of Information on Intrinsic Properties of substances", information on intrinsic properties of substances may be generated by means other than tests e.g. from information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI, "General rules for adaptation of this standard testing regime set out in Annexes VII to X” states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the analogue concept is applied to Monoesters of C16 and C18 (branched and linear) fatty acids with decan-1-ol, data will be generated from data for reference source substance(s) to avoid unnecessary animal testing. Additionally, once the analogue read-across concept is applied, substances will be classified and labelled on this basis.
Based on the analogue read-across approach, the available data on toxicity to reproduction does not meet the classification criteria according to Regulation (EC) No. 1272/2008. However, as no prenatal developmental toxicity study is available, the conclusion for classification is ‘data lacking’.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.